Watson biological and who developed the COVID-19 vaccine?

Watson biological and Zerun Bio develop COVID-19 vaccine.

On July 2, 2002 1 July 21day, the global health non-profit organization Epidemic Prevention Innovation Alliance (CEPI) announced that CEPI would provide 65,438+0,365 to China's innovative vaccine enterprise Shanghai Zerun Biotechnology Co., Ltd. (Zerun Bio) and its parent company China's leading vaccine enterprise Yunnan watson biological Technology Co., Ltd. (watson biological, a company listed on the Growth Enterprise Market of Shenzhen Stock Exchange).

Shanghai Zerun Biotechnology Co., Ltd. is an innovative vaccine company, focusing on the research and development and production of new recombinant human vaccines. Founded in 2003, the company is located in Zhangjiang Hi-tech Park, Pudong New Area, Shanghai. Zerun Bio is a holding subsidiary of Yunnan watson biological Technology Co., Ltd.

Yunnan watson biological Science and Technology Co., Ltd. was established on 200 1, which is a leading vaccine enterprise in China, and is committed to research and development, production and sales of safe and effective vaccines for human use. Headquartered in Kunming, China, watson biological was listed on the Growth Enterprise Market of Shenzhen Stock Exchange in China on 20101,and began to expand its business from traditional vaccines to innovative vaccines.